Bloomberg<\/a>.<\/p>\n\nCele dou\u0103 companii estimeaz\u0103 c\u0103 acordul va fi perfectat \u00eenainte de sf\u00e2r\u015fitul anului. Ac\u0163ionarii InterMune vor primi at\u00e2t numerar, c\u00e2t \u015fi titluri Roche, a declarat compania elve\u0163ian\u0103.<\/p>\n
\n\u00cen urma tranzac\u0163iei, Roche \u00ee\u015fi va extinde paleta de produse cu un nou medicament, pirfenidona, folosit pentru tratarea fibrozei pulmonare idiopatice, o boal\u0103 fatal\u0103 ce se manifest\u0103 prin \u00eengro\u015farea \u0163esuturilor pulmonare. Speran\u0163a de via\u0163\u0103 a pacien\u0163ilor diagnostica\u0163i cu fibroz\u0103 pulmonar\u0103 idiopatic\u0103 este doi-cinci ani. Cauza bolii nu a fost \u00eenc\u0103 detectat\u0103.<\/p>\n
\n“Acordul va permite cre\u015fterea \u015fi consolidarea, la nivel global, al portofoliului Roche pentru tratarea afec\u0163iunilor pulmonare. Estim\u0103m lansarea pirfenidonei in Statele Unite ale Americii \u00een 2014”, a declarat directorul executiv al Roche, Severin Schwan.<\/p>\n
\nAceasta este cea mai mare achizi\u0163ie a companiei elve\u0163iene de dup\u0103 2009, c\u00e2nd a cump\u0103rat 44% din ac\u0163iunile Genentech pentru aproximativ 46,8 miliarde de dolari.<\/p>\n
\n\u00cen iulie, Schwan a reiterat c\u0103 Roche inten\u0163ioneaz\u0103 s\u0103-\u015fi extind\u0103 portofoliul de medicamente \u015fi servicii de diagnostic prin achizi\u0163ia a mai multor produse \u015fi tehnologii. Pentru primul semestru, compania a raportat lichidit\u0103\u0163i suplimentare de aproximativ 8,6 miliarde de dolari.<\/p>\n","protected":false},"excerpt":{"rendered":"
Grupul farmaceutic elve\u0163ian Roche va cump\u0103ra compania de biotehnologie american\u0103 InterMune pentru suma de 8,3 miliarde de dolari, achizi\u0163ie care \u00eei va permite comercializarea pe pia\u0163a din Statele Unite a unui nou medicament pentru tratarea fibrozei pulmonare idiopatice.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[149,8623],"class_list":["post-110895","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-investitii","tag-roche"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/110895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=110895"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/110895\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=110895"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=110895"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=110895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}